ご使用のブラウザでJavaScriptが無効なため、一部の機能をご利用できません。JavaScriptの設定方法は、お使いのブラウザのヘルプページをご覧ください。

お探しの情報は？の内容を非表示にする

がん化学療法レジメン

肺がん・悪性胸膜中皮腫

011101_IP(CDDP+CPT-11)(SCLC) (PDF:108 KB)
011102_CBDCA+CPT-11 (PDF:98 KB)
011103_CPT-11 (PDF:61 KB)
011104_EP(CDDP+ETP) (PDF:107 KB)
011105_CBDCA+ETP (PDF:96 KB)
011106_AMR (PDF:81 KB)
011107_NGT (PDF:73 KB)
011208_CDDP+ETP+RT (PDF:111 KB)
011209_split-CDDP+ETP+RT (PDF:121 KB)
011210_Tarlatamab(1cycle) (PDF:179 KB)
011211_Tarlatamab(2cycle-) (PDF:156 KB)
011212_Durvalumab(maintenance after CRT for LD-SCLC) (PDF:99 KB)
012101_CDDP+VNR (PDF:117 KB)
012102_CDDP+GEM (PDF:112 KB)
012103_CBDCA+GEM (PDF:101 KB)
012104_PEM (PDF:98 KB)
012105_PEM+BV (PDF:126 KB)
012106_CDDP+DTX (PDF:101 KB)
012107_CBDCA+DTX (PDF:90 KB)
012108_DTX (PDF:80 KB)
012109_DTX+BV (PDF:111 KB)
012110_CBDCA+PTX+BV (PDF:128 KB)
012111_CBDCA+PTX (PDF:97 KB)
012112_weeklyPTX+CDBCA (PDF:113 KB)
012113_VNR (PDF:77 KB)
012114_CARNAVAL(nab-PTX+CBDCA+BV) (PDF:119 KB)
012116_TKI+BV (PDF:109 KB)
012117_CBDCA+PEM+BV (PDF:117 KB)
012214_CDDP+DTX+RT (PDF:111 KB)
012215_CBDCA+PTX+RT (PDF:74 KB)
012220_nab-PTX+CBDCA (PDF:109 KB)
012221_low dose CBDCA+RT (PDF:72 KB)
012222_CBDCA+S-1 (PDF:89 KB)
012224_weekly nab-PTX (PDF:88 KB)
012225_CBDCA+VNR (PDF:106 KB)
012227_CDGP+DTX (PDF:109 KB)
012230_Nivolumab (PDF:80 KB)
012238_IP(CDDP+CPT-11)(NSCLC) (PDF:106 KB)
012239_RAM+DTX (PDF:109 KB)
012240_CBDCA(AUC6)+PEM (PDF:112 KB)
012241_Pembrolizumab (PDF:70 KB)
012253_Atezolizumab (PDF:82 KB)
012260_Pembrolizumab+CDDP+PEM (PDF:166 KB)
012261_Pembrolizumab+CBDCA+PEM (PDF:144 KB)
012262_Pembrolizumab+PEM(maintenance) (PDF:133 KB)
012263_Pembrolizumab+CBDCA+nab-PTX (PDF:144 KB)
012264_Pembrolizumab(maintenance) (PDF:111 KB)
012265_CDDP(split)+VNR (PDF:110 KB)
012266_Atezolizumab+CBDCA+ETP (PDF:116 KB)
012267_Atezolizumab(maintenance) (PDF:114 KB)
012268_Atezolizumab+CBDCA+nab-PTX (PDF:145 KB)
012271_Durvalumab+CDDP+ETP (PDF:138 KB)
012272_Durvalumab(maintenance) (PDF:86 KB)
012275_Nivolumab(Q4W) (PDF:80 KB)
012281_RAM+erlotinib gefitinib (PDF:101 KB)
012282_Necitumumab+CDDP+GEM (PDF:143 KB)
012283_Necitumumab(maintenance) (PDF:100 KB)
012284_Atezolizumab+BV+CBDCA+PTX (PDF:156 KB)
012285_Atezolizumab+BV(maintenance) (PDF:111 KB)
012288_Durvalumab+CBDCA+ETP (PDF:116 KB)
012290_Pembrolizumab+CBDCA+PTX (PDF:139 KB)
012291_Atezolizumab+CDDP+PEM (PDF:169 KB)
012292_Atezolizumab+CBDCA+PEM (PDF:145 KB)
012293_Atezolizumab+PEM(maintenance) (PDF:133 KB)
012294_Atezolizumab(adjuvant) (PDF:91 KB)
012295_CDDP+S-1+RT (PDF:123 KB)
012296_Durvalumab+Tremelimumab+CBDCA+nab-PTX (PDF:148 KB)
012297_Durvalumab+Tremelimumab(maintenance1) (PDF:117 KB)
012298_Durvalumab(maintenance2) (PDF:115 KB)
012299_Nivolumab+Ipilimumab (PDF:94 KB)
012300_Durvalumab(maintenance after CRT) (PDF:89 KB)
012303_Trastuzumab Deruxtecan (PDF:105 KB)
012307_Nivolumab+CBDCA+PEM(neo adjuvant) (PDF:141 KB)
012308_Nivolumab+CDDP+PEM(neo adjuvant) (PDF:163 KB)
012309_Nivolumab+CBDCA+PTX(neo adjuvant) (PDF:134 KB)
012310_CBDCA+PEM+Osimertinib (PDF:119 KB)
012311_CDDP+PEM+Osimertinib (PDF:123 KB)
012312_PEM(maintenance)+Osimertinib (PDF:109 KB)
012314_Pembrolizumab+CDDP+GEM(neo adjuvant) (PDF:162 KB)
012315_Pembrolizumab+CDDP+PEM(neo adjuvant) (PDF:162 KB)
012316_Pembrolizumab(adjuvant) (PDF:87 KB)
012317_CDDP+PEM(adjuvant) (PDF:140 KB)
012320,012321_Amivantamab+CBDCA+PEM(1cycle) (PDF:177 KB)
012322,012323_Amivantamab+CBDCA+PEM(2cycle) (PDF:142 KB)
012324,012325_Amivantamab+CBDCA+PEM(3-4cycle) (PDF:142 KB)
012326,012327_Amivantamab+PEM(maintenance) (PDF:135 KB)
012338_Durvalumab+CDDP+PEM(neo adjuvant) (PDF:152 KB)
012339_Durvalumab+CBDCA+PEM(neo adjuvant) (PDF:143 KB)
012340_Durvalumab+CBDCA+PTX(neo adjuvant) (PDF:246 KB)
012341_Durvalumab(adjuvant) (PDF:92 KB)
013101_CDDP+PEM (PDF:118 KB)
013102_CBDCA(AUC5)+PEM (PDF:111 KB)
013103_CDDP+PEM+BV (PDF:135 KB)
013106_Nivolumab (PDF:82 KB)
013107_Nivolumab(Q4W) (PDF:84 KB)
013108_Nivolumab+Ipilimumab (PDF:94 KB)

乳がん

020101_CMF(CPA+MTX+5-FU) (PDF:93 KB)
020102_AC(DXR+CPA) (PDF:107 KB)
020103_FEC(5-FU+EPI+CPA) (PDF:99 KB)
020104_EC(EPI+CPA) (PDF:93 KB)
020105_DTX (PDF:80 KB)
020106_DTX+Trastuzumab(1cycle) (PDF:93 KB)
020107_DTX+Trastuzumab(2cycle-) (PDF:93 KB)
020108_PTX (PDF:82 KB)
020109_PTX+Trastuzumab(1cycle) (PDF:95 KB)
020110_PTX+Trastuzumab(2cycle-) (PDF:94 KB)
020114_triweekly Trastuzumab(1cycle) (PDF:64 KB)
020115_triweekly Trastuzumab(2cycle-) (PDF:65 KB)
020116_weekly Trastuzumab(1cycle) (PDF:63 KB)
020117_weekly Trastuzumab(2cycle-) (PDF:62 KB)
020118_TC(DTX+CPA) (PDF:95 KB)
020119_TC(DTX+CPA)+Trastuzumab(1cycle) (PDF:107 KB)
020120_TC(DTX+CPA)+Trastuzumab(2cycle-) (PDF:107 KB)
020121_VNR (PDF:70 KB)
020122_VNR+Trastuzumab(1cycle) (PDF:89 KB)
020123_VNR+Trastuzumab(2cycle-) (PDF:89 KB)
020124_GEM (PDF:82 KB)
020125_GEM+Trastuzumab(1cycle) (PDF:105 KB)
020126_GEM+Trastuzumab(2cycle-) (PDF:101 KB)
020127_GEM+PTX (PDF:102 KB)
020128_GEM+PTX+Trastuzumab(1cycle) (PDF:113 KB)
020129_GEM+PTX+Trastuzumab(2cycle-) (PDF:111 KB)
020130_GEM+weeklyPTX (PDF:94 KB)
020131_GEM+weeklyPTX+Trastuzumab(1cycle) (PDF:117 KB)
020132_GEM+weeklyPTX+Trastuzumab(2cycle-) (PDF:120 KB)
020133_nab-PTX (PDF:85 KB)
020134_weeklyPTX+BV (PDF:117 KB)
020142_Eribulin (PDF:78 KB)
020153_Perjeta+Trastuzumab+DTX(1cycle) (PDF:103 KB)
020154_Perjeta+Trastuzumab+DTX(2cycle-) (PDF:98 KB)
020155_Perjeta+Trastuzumab(1cycle) (PDF:91 KB)
020156_Perjeta+Trastuzumab(2cycle-) (PDF:87 KB)
020157_Perjeta+Trastuzumab+PTX(1cycle) (PDF:90 KB)
020158_Perjeta+Trastuzumab+PTX(2cycle-) (PDF:87 KB)
020160_Perjeta+Trastuzumab+GEM(1cycle) (PDF:89 KB)
020161_Perjeta+Trastuzumab+GEM(2cycle-) (PDF:83 KB)
020162_Eribulin+Trastuzumab(1cycle) (PDF:99 KB)
020163_Eribulin+Trastuzumab(2cycle-) (PDF:98 KB)
020164_T-DM1 (PDF:70 KB)
020165_Perjeta+Trastuzumab+weeklyPTX(1cycle) (PDF:123 KB)
020166_Perjeta+Trastuzumab+weeklyPTX(2cycle-) (PDF:117 KB)
020167_Perjeta+Trastuzumab+Eribulin(1cycle) (PDF:108 KB)
020168_Perjeta+Trastuzumab+Eribulin(2cycle-) (PDF:102 KB)
020169_Perjeta+Trastuzumab+VNR(1cycle) (PDF:96 KB)
020170_Perjeta+Trastuzumab+VNR(2cycle-) (PDF:92 KB)
020171_CPT-11 (PDF:80 KB)
020233_Dose-Dense AC (PDF:108 KB)
020234_Dose-Dense PTX (PDF:104 KB)
020235_weeklyPTX+Trastuzumab(1cycle) (PDF:114 KB)
020236_weeklyPTX+Trastuzumab(2cycle-) (PDF:113 KB)
020237_GEM+BV (PDF:102 KB)
020238_Atezolizumab+nab-PTX (PDF:117 KB)
020239_Perjeta+Trastuzumab+CBDCA+DTX(1cycle) (PDF:129 KB)
020240_Perjeta+Trastuzumab+CBDCA+DTX(2cycle-) (PDF:127 KB)
020241_Trastuzumab Deruxtecan (PDF:102 KB)
020242_T-DM1(adjuvant) (PDF:87 KB)
020243_Pembrolizumab(Q3W)+CBDCA+GEM (PDF:126 KB)
020244_Pembrolizumab(Q6W)+CBDCA+GEM (PDF:129 KB)
020245_Pembrolizumab(Q3W)+nab-PTX (PDF:135 KB)
020246_Pembrolizumab(Q6W)+nab-PTX (PDF:128 KB)
020247_Pembrolizumab(Q3W)+PTX (PDF:134 KB)
020248_Pembrolizumab(Q6W)+PTX (PDF:129 KB)
020249_weeklyPTX (PDF:92 KB)
020250_Pembrolizumab+CBDCA(AUC1.5)+PTX (PDF:127 KB)
020251_Pembrolizumab+CBDCA(AUC5)+PTX (PDF:130 KB)
020252_Pembrolizumab+AC(DXR+CPA) (PDF:118 KB)
020253_Pembrolizumab (PDF:81 KB)
020254_Trastuzumab Deruxtecan(HER2-low) (PDF:101 KB)
020255_PHESGO(1cycle) (PDF:105 KB)
020256_PHESGO(2cycle-) (PDF:103 KB)
020257_weeklyPTX+PHESGO(1cycle) (PDF:148 KB)
020258_weeklyPTX+PHESGO(2cycle-) (PDF:142 KB)
020259_DTX+PHESGO(1cycle) (PDF:125 KB)
020260_DTX+PHESGO(2cycle-) (PDF:118 KB)
020261_Eribulin+PHESGO(1cycle) (PDF:127 KB)
020262_Eribulin+PHESGO(2cycle-) (PDF:121 KB)
020263_GEM+PHESGO(1cycle) (PDF:124 KB)
020264_GEM+PHESGO(2cycle-) (PDF:117 KB)
020265_VNR+PHESGO(1cycle) (PDF:127 KB)
020266_VNR+PHESGO(2cycle-) (PDF:119 KB)
020267_AC(DXR+CPA)(G-LASTA BodyPod) (PDF:108 KB)
020268_Sacituzumab Govitecan (PDF:124 KB)
020269_Sacituzumab Govitecan(PEGFIL) (PDF:137 KB)
020270_Sacituzumab Govitecan(G-LASTA BodyPod) (PDF:137 KB)
020271_Datopotamab Deruxtecan (PDF:113 KB)

胃がん

030101_CDDP+CPT-11 (PDF:77 KB)
030102_S-1+CDDP(short hydration) (PDF:104 KB)
030103_S-1+CPT-11 (PDF:69 KB)
030105_CPT-11 (PDF:61 KB)
030106_S-1+DTX (PDF:90 KB)
030107_DTX (PDF:73 KB)
030108_weeklyPTX (PDF:80 KB)
030110_Capecitabine+CDDP+Trastuzumab(1cycle) (PDF:139 KB)
030111_Capecitabine+CDDP+Trastuzumab(2cycle-) (PDF:139 KB)
030112_Capecitabine+CDDP (PDF:128 KB)
030114_nab-PTX (PDF:83 KB)
030115_CAPOX(Capecitabine+L-OHP) (PDF:112 KB)
030209_S-1+CDDP (PDF:103 KB)
030210_Ramucirumab (PDF:72 KB)
030211_weeklyPTX+Ramucirumab (PDF:111 KB)
030212_Nivolumab (PDF:83 KB)
030213_weekly nab-PTX (PDF:69 KB)
030214_weekly nab-PTX+Ramucirumab (PDF:111 KB)
030215_Capecitabine+Trastuzumab(1cycle) (PDF:113 KB)
030216_Capecitabine+Trastuzumab(2cycle-) (PDF:114 KB)
030217_Trastuzumab Deruxtecan (PDF:104 KB)
030218_Nivolumab(Q4W) (PDF:82 KB)
030219_SOX(S-1+L-OHP)+Nivolmab (PDF:107 KB)
030220_TAS-102+Ramucirumab (PDF:123 KB)
030221_CAPOX+Trastuzumab(1cycle) (PDF:119 KB)
030222_CAPOX+Trastuzumab(2cycle-) (PDF:117 KB)
030223_SOX(S-1+L-OHP)130mg m2 (PDF:99 KB)
030224_CAPOX+Zolbetuximab(1cycle) (PDF:159 KB)
030225_CAPOX+Zolbetuximab(2cycle-) (PDF:153 KB)
030226_mFOLFOX6+Zolbetuximab(1cycle) (PDF:444 KB)
030227_mFOLFOX6+Zolbetuximab(2cycle-) (PDF:437 KB)
030228_CAPOX+Trastuzumab+Pembrolizumab(1cycle) (PDF:139 KB)
030229_CAPOX+Trastuzumab+Pembrolizumab(2cycle-) (PDF:135 KB)
030231_CAPOX+Pembrolizumab (PDF:126 KB)

食道がん

040101_DTX (PDF:80 KB)
040208_weeklyPTX (PDF:77 KB)
040209_Nivolumab (PDF:82 KB)
040210_Nivolumab(Q4W) (PDF:82 KB)
040213_Nivolumab+Ipilimumab (PDF:113 KB)
040214_Nivolumab(adjuvant)(Q4W) (PDF:107 KB)

大腸がん

050101_mFOLFOX6(l-LV+L-OHP+5-FU) (PDF:447 KB)
050102_mFOLFOX6(l-LV+L-OHP+5-FU)+BV (PDF:451 KB)
050105_FOLFIRI(l-LV+CPT-11+5-FU) (PDF:444 KB)
050106_FOLFIRI(l-LV+CPT-11+5-FU)+BV (PDF:446 KB)
050109_CPT-11+C-mab(1cycle) (PDF:106 KB)
050110_CPT-11+C-mab(2cycle-) (PDF:101 KB)
050113_CAPOX(Capecitabine+L-OHP) (PDF:110 KB)
050114_CAPOX(Capecitabine+L-OHP)+BV (PDF:117 KB)
050115_IRIS(CPT-11+S-1) (PDF:81 KB)
050116_FOLFIRI(l-LV+CPT-11+5-FU)+P-mab (PDF:453 KB)
050117_IRIS(CPT-11+S-1)+BV (PDF:86 KB)
050118_SOX(S-1+L-OHP)+BV (PDF:98 KB)
050120_P-mab (PDF:66 KB)
050121_Capecitabine+BV (PDF:98 KB)
050122_mFOLFOX6(l-LV+L-OHP+5-FU)+P-mab (PDF:455 KB)
050123_FOLFIRI(l-LV+CPT-11+5-FU)+RAM (PDF:462 KB)
050124_CPT-11+P-mab (PDF:77 KB)
050125_mFOLFOXIRI+BV(induction) (PDF:500 KB)
050126_5-FU+l-LV+BV(maintenance) (PDF:482 KB)
050127_TAS-102+BV (PDF:116 KB)
050133_C-mab(Q2W) (PDF:86 KB)
050134_Encorafenib+Binimetinib+C-mab(Q2W) (PDF:111 KB)
050135_Encorafenib+C-mab(Q2W) (PDF:106 KB)
050136_FOLFIRI+C-mab(Q2W) (PDF:469 KB)
050137_mFOLFOX6+C-mab(Q2W) (PDF:457 KB)
050138_Pertuzumab+Trastuzumab(1cycle) (PDF:95 KB)
050139_Pertuzumab+Trastuzumab(2cycle-) (PDF:97 KB)

肝臓がん

060207_low dose FP(5-FU+CDDP) (PDF:120 KB)
060208_Ramucirumab (PDF:91 KB)
060209_Atezolizumab+BV (PDF:180 KB)
060210_Durvalumab+Tremelimumab (PDF:87 KB)
060211_Nivolumab+Ipilimumab (PDF:83 KB)
060212_Durvalumab(maintenance) (PDF:81 KB)
060213_Nivolumab(maintenance)(Q4W) (PDF:78 KB)

胆道がん

070101_CDDP+GEM (PDF:75 KB)
070102_GEM (PDF:77 KB)
070103_GCS(GEM+CDDP+S-1) (PDF:102 KB)
070104_Durvalumab+CDDP+GEM (PDF:109 KB)
070105_Durvalumab+CDDP+GEM(-30kg) (PDF:108 KB)
070106_Durvalumab(maintenance) (PDF:83 KB)
070107_Durvalumab(maintenance)(-30kg) (PDF:85 KB)
070108_Pembrolizumab+CDDP+GEM (PDF:109 KB)
070109_Pembrolizumab+GEM(maintenance) (PDF:99 KB)
070110_Pembrolizumab+GEM(maintenance)(Q6W) (PDF:110 KB)

膵臓がん

080101_GEM (PDF:78 KB)
080103_S-1+GEM (PDF:90 KB)
080104_GEM+Erlotinib (PDF:92 KB)
080105_mFOLFIRINOX (PDF:476 KB)
080107_nab-PTX+GEM (PDF:91 KB)
080108_nal-IRI+5-FU l-LV (PDF:503 KB)
080109_mFOLFIRINOX(-CPT-11) (PDF:461 KB)

NET・NEC

081101_STZ+5-FU (PDF:104 KB)
081102_EP(CDDP+ETP) (PDF:109 KB)
081103_CPT-11 (PDF:75 KB)
081104_AMR (PDF:85 KB)

婦人科

100101_weeklyTC (PDF:97 KB)
100102_weeklyDC (PDF:90 KB)
101102_dose denseTC (PDF:109 KB)
101103_weeklyTN (PDF:94 KB)
101105_weeklyDN (PDF:85 KB)
101107_CPT-11+CBDCA (PDF:97 KB)
101108_CPT-11 (PDF:59 KB)
101109_GC(GEM+CBDCA) (PDF:108 KB)
101110_GEM (PDF:82 KB)
101111_DXL (PDF:81 KB)
101113_CD(CBDCA+DXL) (PDF:111 KB)
101114_DXL+GEM (PDF:102 KB)
101201_monthlyTC (PDF:98 KB)
101204_monthlyDC (PDF:94 KB)
101206_IP(CPT-11+CDDP) (PDF:100 KB)
101213,101214_CPB (PDF:141 KB)
101215,101216_CDB(PTX unfit) (PDF:140 KB)
101217_DXL+BV (PDF:95 KB)
101218_NGT+BV (PDF:91 KB)
102101_TP(PTX+CDDP) (PDF:108 KB)
103101_GD(GEM+DTX) (PDF:95 KB)
103202_IAP(IFM+THP+CDDP) (PDF:138 KB)
103203_AP(DXR+CDDP) (PDF:101 KB)
104103_ACT-D(pulse) (PDF:85 KB)
104104_ACT-D(5days) (PDF:87 KB)

泌尿器

111101_GC(GEM+CDDP) (PDF:119 KB)
111102_GEM+CBDCA (PDF:106 KB)
111103_GCP(GEM+CDDP+PTX) (PDF:126 KB)
111104_GEM+CBDCA+PTX (PDF:120 KB)
111105_GEM (PDF:78 KB)
111206_MVAC (PDF:137 KB)
111210_Pembrolizumab (PDF:65 KB)
111211_Avelumab (PDF:91 KB)
111212_Enfortumab Vedotin (PDF:91 KB)
111214_Nivolumab(adjuvant)(Q4W) (PDF:82 KB)
111215_Enfortumab Vedotin+Pembrolizumab (PDF:98 KB)
111216_Enfortumab Vedotin(maintenance) (PDF:85 KB)
112101_DTX (PDF:92 KB)
112104_Cabazitaxel (PDF:105 KB)
112105_DTX+Darolutamide (PDF:89 KB)
114102_Temsirolimus (PDF:56 KB)
114103_Nivolumab (PDF:73 KB)
114104_Nivolumab+Ipilimumab (PDF:87 KB)
114105_Pembrolizumab+Axitinib (PDF:94 KB)
114106_Avelumab+Axitinib (PDF:99 KB)
114107_Nivolumab+Cabozantinib (PDF:94 KB)
114108_Pembrolizumab+Lenvatinib (PDF:87 KB)
114109_Pembrolizumab(adjuvant)(Q6W) (PDF:86 KB)

悪性リンパ腫

120201_Rituximab (PDF:82 KB)
120202_CHOP (PDF:106 KB)
120203_R-CHOP (PDF:125 KB)
120204_CVP (PDF:105 KB)
120205_R-CVP (PDF:124 KB)
120206_THP-COP (PDF:113 KB)
120207_R-THP-COP (PDF:125 KB)
120222_ABVD (PDF:109 KB)
120223_Bendamustine (PDF:90 KB)
120224_R-Bendamustine(3days) (PDF:103 KB)
120245_Brentuximab Vedotin (PDF:76 KB)
120247_Nivolumab (PDF:76 KB)
120250_A-AVD (PDF:138 KB)
120251_G-CHOP(1cycle) (PDF:140 KB)
120252_G-CHOP(2-6cycle) (PDF:132 KB)
120253_G-CHOP(Obinutuzumab)(7-8cycle) (PDF:94 KB)
120254_G-CVP(1cycle) (PDF:138 KB)
120255_G-CVP(2-8cycle) (PDF:124 KB)
120256_G-Bendamustine(1cycle) (PDF:117 KB)
120257_G-Bendamustine(2-6cycle)(3days) (PDF:109 KB)
120258_Obinutuzumab(maintenance) (PDF:92 KB)
120268_R2(RIT+Lenalidomide)(1cycle) (PDF:97 KB)
120269_R2(RIT+Lenalidomide)(2-5cycle) (PDF:96 KB)
120270_Pembrolizumab (PDF:76 KB)
120271_A-CHP (PDF:135 KB)
120272_Pola-BR(1cycle) (PDF:128 KB)
120273_Pola-BR(2cycle-) (PDF:121 KB)
120275_Pola-R-CHP (PDF:138 KB)
120294_R-Bendamustine(2days) (PDF:101 KB)
120295_G-Bendamustine(2-6cycle)(2days) (PDF:108 KB)
120300_Rituximab(90min) (PDF:93 KB)
120301_R-CHOP(1day) (PDF:131 KB)
120302_R-CHOP(RIT90min) (PDF:134 KB)
120303_Epcoritamab(1cycle) (PDF:208 KB)
120304_Epcoritamab(2-3cycle) (PDF:193 KB)
120305_Epcoritamab(4-9cycle) (PDF:193 KB)
120306_Epcoritamab(10cycle-) (PDF:193 KB)
120307_R2(90min)(1cycle) (PDF:102 KB)
120308_R2(90min)(2-5cycle) (PDF:101 KB)
120309_Pola-R-CHP(RIT90min) (PDF:136 KB)
120310_Pola-BR(RIT90min) (PDF:125 KB)
120311_R-CVP(RIT90min) (PDF:120 KB)
120312_R-CVP(1day) (PDF:117 KB)
120321_DRC (PDF:97 KB)
120322_BDR(1cycle) (PDF:76 KB)
120323_BDR(2,5cycle) (PDF:98 KB)
120324_BDR(3,4cycle) (PDF:78 KB)
120325_G-CHOP(2-6cycle)(G short duration) (PDF:139 KB)
120326_G-CHOP(Obinutuzumab)(7-8cycle)(G short duration) (PDF:95 KB)
120327_G-CVP(2-8cycle)(G short duration) (PDF:131 KB)
120328_G-Bendamustine(2-6cycle)(G short duration) (PDF:109 KB)
120329_Obinutuzumab(maintenance)(G short duration) (PDF:95 KB)
120330_Mosunetuzumab(1cycle) (PDF:388 KB)
120331_Mosunetuzumab(2cycle) (PDF:386 KB)
120332_Mosunetuzumab(3cycle-) (PDF:390 KB)
120333_Epcoritamab(1cycle)(FL G1-3A) (PDF:212 KB)

多発性骨髄腫

130202_Bd (PDF:72 KB)
130204_weekly Bd (PDF:73 KB)
130205_Kd(1cycle) (PDF:96 KB)
130206_Kd(2cycle-) (PDF:84 KB)
130207_Bd(sc) (PDF:68 KB)
130208_weekly Bd(sc) (PDF:69 KB)
130209_DLd(1cycle) (PDF:152 KB)
130210_DLd(2cycle) (PDF:128 KB)
130211_DLd(3-6cycle) (PDF:129 KB)
130212_DLd(7cycle-) (PDF:129 KB)
130213_DBd(1cycle) (PDF:162 KB)
130214_DBd(2-3cycle) (PDF:146 KB)
130215_DBd(4-8cycle) (PDF:135 KB)
130216_DBd(9cycle-) (PDF:118 KB)
130217_ELd(1cycle) (PDF:143 KB)
130218_ELd(3cycle-) (PDF:125 KB)
130219_ELd(2cycle) (PDF:120 KB)
130220_KRd(1cycle) (PDF:123 KB)
130221_KRd(2-12cycle) (PDF:111 KB)
130222_KRd(13-18cycle) (PDF:124 KB)
130223_weeklyKd(1cycle) (PDF:110 KB)
130224_weeklyKd(2cycle-) (PDF:100 KB)
130225_DMPB(1cycle) (PDF:184 KB)
130226_DMPB(2-9cycle) (PDF:139 KB)
130227_DMPB(10cycle-) (PDF:111 KB)
130228_EPd(1cycle) (PDF:147 KB)
130229_EPd(2cycle) (PDF:123 KB)
130230_EPd(3cycle) (PDF:127 KB)
130231_EPd(4cycle-) (PDF:127 KB)
130232,130234_IsaPd(1cycle) (PDF:176 KB)
130233,130235_IsaPd(2cycle-) (PDF:144 KB)
130236_DLd(sc)(1cycle) (PDF:122 KB)
130237_DLd(sc)(2cycle) (PDF:119 KB)
130238_DLd(sc)(3-6cycle) (PDF:120 KB)
130239_DLd(sc)(7cycle-) (PDF:121 KB)
130240_DKd(sc)(1cycle) (PDF:158 KB)
130241_DKd(sc)(2cycle) (PDF:134 KB)
130242_DKd(sc)(3-6cycle) (PDF:129 KB)
130243_DKd(sc)(7cycle-) (PDF:130 KB)
130244_DMPB(sc)(1cycle) (PDF:149 KB)
130245_DMPB(sc)(2-9cycle) (PDF:131 KB)
130246_DMPB(sc)(10cycle-) (PDF:102 KB)
130247_DBd(sc)(1cycle) (PDF:137 KB)
130248_DBd(sc)(2-3cycle) (PDF:134 KB)
130249_DBd(sc)(4-8cycle) (PDF:125 KB)
130250_DBd(sc)(9cycle-) (PDF:108 KB)
130251_Isatuximab(1cycle) (PDF:166 KB)
130252_Isatuximab(2cycle-) (PDF:128 KB)
130253,130254_Isa+d(1cycle) (PDF:173 KB)
130255,130256_Isa+d(2cycle-) (PDF:139 KB)
130257_IsaKd(1cycle) (PDF:221 KB)
130258_IsaKd(2cycle-) (PDF:159 KB)
130259_BLd (PDF:95 KB)
130260_BLd(sc) (PDF:89 KB)
130261_DPd(sc)(1cycle) (PDF:117 KB)
130262_DPd(sc)(2cycle) (PDF:113 KB)
130263_DPd(sc)(3-6cycle) (PDF:114 KB)
130264_DPd(sc)(7cycle-) (PDF:115 KB)
130265_Elranatamab(day1,4,8) (PDF:278 KB)
130266_Elranatamab(day15-) (PDF:258 KB)
130267,130271_IsaBLd(1cycle) (PDF:232 KB)
130268,130272_IsaBLd(2-4cycle) (PDF:193 KB)
130269,130273_IsaBLd(5-17cycle) (PDF:140 KB)
130270,130274_IsaBLd(18cycle-) (PDF:152 KB)
130275_DPd(1cycle) (PDF:153 KB)
130276_DPd(2cycle) (PDF:129 KB)
130277_DPd(3-6cycle) (PDF:130 KB)
130278_DPd(7cycle-) (PDF:130 KB)

ALアミロイドーシス

133001_DCyBorD(sc)(1-2cycle) (PDF:130 KB)
133002_DCyBorD(sc)(3-6cycle) (PDF:133 KB)
133003_DCyBorD(sc)(7cycle-) (PDF:93 KB)

白血病

140215_ATL_Mogamulizumab (PDF:109 KB)
140254_CLL_R-FC(F-Ara-A+CPA)(1cycle) (PDF:121 KB)
140255_CLL_R-FC(F-Ara-A+CPA)(2cycle-) (PDF:122 KB)
140257_AML_Azacitidine+Venetoclax (PDF:126 KB)
140258_AML_Azacitidine(sc)+Venetoclax (PDF:117 KB)
140273_ALL(induction)_Blinatumomab(45kg-)(1cycle)(4days-3days) (PDF:184 KB)
140274_ALL(induction)_Blinatumomab(45kg-)(2cycle)(4days-3days) (PDF:161 KB)
140275_ALL(consolidation)_Blinatumomab(45kg-)(4days-3days) (PDF:161 KB)
140276_ALL(maintenance)_Blinatumomab(45kg-)(4days-3days) (PDF:161 KB)
140277_ALL(induction)_Blinatumomab(45kg-)(1cycle)(3days-4days) (PDF:184 KB)
140278_ALL(induction)_Blinatumomab(45kg-)(2cycle)(3days-4days) (PDF:160 KB)
140279_ALL(consolidation)_Blinatumomab(45kg-)(3days-4days) (PDF:160 KB)
140280_ALL(maintenance)_Blinatumomab(45kg-)(3days-4days) (PDF:160 KB)
140281_ALL(induction)_Blinatumomab(-45kg)(1cycle)(4days-3days) (PDF:189 KB)
140282_ALL(induction)_Blinatumomab(-45kg)(2cycle)(4days-3days) (PDF:164 KB)
140283_ALL(consolidation)_Blinatumomab(-45kg)(4days-3days) (PDF:164 KB)
140284_ALL(maintenance)_Blinatumomab(-45kg)(4days-3days) (PDF:164 KB)
140285_ALL(induction)_Blinatumomab(-45kg)(1cycle)(3days-4days) (PDF:189 KB)
140286_ALL(induction)_Blinatumomab(-45kg)(2cycle)(3days-4days) (PDF:164 KB)
140287_ALL(consolidation)_Blinatumomab(-45kg)(3days-4days) (PDF:164 KB)
140288_ALL(maintenance)_Blinatumomab(-45kg)(3days-4days) (PDF:163 KB)
140289_Ph+ALL MRD2023(45kg-)(P-D1)(4days-3days) (PDF:207 KB)
140290_Ph+ALL MRD2023(45kg-)(P-D’2-5)(4days-3days) (PDF:188 KB)
140291_Ph+ALL MRD2023(45kg-)(P-D1)(3days-4days) (PDF:207 KB)
140292_Ph+ALL MRD2023(45kg-)(P-D’2-5)(3days-4days) (PDF:188 KB)
140293_Ph+ALL MRD2023(-45kg)(P-D1)(4days-3days) (PDF:215 KB)
140294_Ph+ALL MRD2023(-45kg)(P-D’2-5)(4days-3days) (PDF:192 KB)
140295_Ph+ALL MRD2023(-45kg)(P-D1)(3days-4days) (PDF:215 KB)
140296_Ph+ALL MRD2023(-45kg)(P-D’2-5)(3days-4days) (PDF:193 KB)
141001_AML_Azacitidine+Ivosidenib (PDF:106 KB)
141002_AML_Azacitidine(sc)+Ivosidenib (PDF:98 KB)

MDS

150202_Azacitidine (PDF:77 KB)
150204_Azacitidine(sc) (PDF:84 KB)

頭頸部がん

160101_BRT_Cetuximab(1cycle) (PDF:58 KB)
160102_BRT_Cetuximab(2cycle-) (PDF:57 KB)
160214_C-mab(maintenance) (PDF:64 KB)
160215_weekly PTX (PDF:86 KB)
160216_triweekly DTX (PDF:84 KB)
160217_Nivolumab (PDF:80 KB)
160220_weekly PTX+C-mab(1cycle) (PDF:72 KB)
160221_weekly PTX+C-mab(2cycle-) (PDF:70 KB)
160223_Pembrolizumab(maintenance) (PDF:83 KB)
160224_Pembrolizumab (PDF:80 KB)
160225_Pembrolizumab(Q6W)(maintenance) (PDF:84 KB)
160226_Pembrolizumab(Q6W) (PDF:82 KB)
160227_Nivolumab(Q4W) (PDF:82 KB)
160229_DTX+Trastuzumab(1cycle) (PDF:95 KB)
160230_DTX+Trastuzumab(2cycle-) (PDF:99 KB)
160231_Trastuzumab(maintenance) (PDF:89 KB)
160233_CDDP+DTX (PDF:122 KB)
160234_weekly PCE(1cycle) (PDF:121 KB)
160235_weekly PCE(2-6cycle) (PDF:108 KB)
160236_weekly PCE(7cycle-) (PDF:86 KB)

MSI-High

270000_MSI-High_Pembrolizumab (PDF:90 KB)

TMB-High

270001_TMB-High_Pembrolizumab (PDF:91 KB)

胸腺腫瘍

013201_CAP(CPA+DXR+CDDP) (PDF:107 KB)

悪性軟部腫瘍

210203_AIM(ADM+IFM+Mesna) (PDF:132 KB)
210205_Eribulin (PDF:65 KB)

悪性神経膠腫

220101_Bevacizumab(Q3W) (PDF:78 KB)
220102_Bevacizumab(Q2W) (PDF:78 KB)

悪性黒色腫

015101_DTIC (PDF:83 KB)
250101_Nivolumab (PDF:76 KB)
250102_Nivolumab+Ipilimumab (PDF:87 KB)
250103_Nivolumab(Q4W) (PDF:78 KB)

原発不明がん

016101_Nivolumab (PDF:99 KB)
016102_Nivolumab(Q4W) (PDF:100 KB)

転移性骨腫瘍

210101_Denosumab (PDF:86 KB)
210102_Zoledronic Acid (PDF:88 KB)

Adobe Readerのダウンロードページへ（別ウィンドウ）

PDF形式のファイルをご覧いただく場合には、Adobe Readerが必要です。
Adobe Readerをお持ちでない方は、バナーのリンク先から無料ダウンロードしてください。